Frontlight ResearchEarly access
Nephrotic syndrome trials in Italy
7 trials · From ClinicalTrials.gov, checked 17 November 2026. Ask the study team whether a trial fits you.
- Phase 2Taking peopleA Study to Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease
- Where
- Brescia, Florence, Monza, Naples
- Age
- 16 years to 75 years
- People
- 84 worldwide
- Run by
- Sanofi
See details and how to joinNCT06500702 - Phase 2Taking peopleStudy of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases
- Where
- Bari, Genoa, Milan, Padova, Rome
- Age
- 1 year to 17 years
- People
- 67 worldwide
- Run by
- Travere Therapeutics, Inc.
See details and how to joinNCT05003986 · EU 2023-505497-14-00 - No phaseTaking peopleSLIT ABS: Study on Patients With Autoimmune Podocytopathy
- Where
- Bagno a Ripoli, Bologna, Florence, Genova, Parma, Pisa, Prato, Reggio Emilia
- Age
- 0 years to 99 years
- People
- 50 worldwide
- Run by
- Meyer Children's Hospital IRCCS
See details and how to joinNCT07516964 - No phaseTaking peopleMultitarget Strategy for Primary Podocytopathies
- Where
- Milan, Pavia
- People
- 150
- Run by
- Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
See details and how to joinNCT06718894 - No phaseTaking peopleAn Outcome Analysis of Primary Membranous Nephropathy
- Where
- Bergamo, Ranica
- Age
- 18 years and over
- People
- 500
- Run by
- Mario Negri Institute for Pharmacological Research
See details and how to joinNCT06242327 - Phase 2Taking peopleObinutuzumab in Adult Rituximab-Dependent Nephrotic Syndrome
- Where
- Ranica
- Age
- 18 years and over
- People
- 10
- Run by
- Mario Negri Institute for Pharmacological Research
See details and how to joinNCT07233330 · EU 2025-523306-33-00 - No phaseTaking peopleAutoantibodies Against-nephrin in Idiopathic Nephrotic Syndrome
- Where
- Ranica
- Age
- 18 years and over
- People
- 100
- Run by
- Mario Negri Institute for Pharmacological Research
See details and how to joinNCT06334692